Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac gel 1% versus Voltaren Emulgel 1% in traumatic musculoskeletal inflammation
2010-020521-40Phase 3Completed
- Sponsor
- Epifarma
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in Traumatic soft tissue injury (TSTI) and musculoskeletal inflammation (2 arms), sponsored by Epifarma. Primary endpoint: Primary efficacy variable: response to treatment. Started Jul 2010; status: completed.
02
Drugs
diclofenac
03
Conditions
Traumatic soft tissue injury (TSTI)musculoskeletal inflammation
Beyond the preview
Go deeper on 2010-020521-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020521-40.